Make therapeutic breakthroughs with bulk immune profiling
Leverage bulk VDJ sequencing to advance key therapeutics areas with multi-chain repertoire analysis
Discover how our sensitive, quantitative, and high-throughput assay, RepSeq+, provides detailed clonality and diversity insights to drive forward your clinical development and drug discovery programs.
Potential Breakthroughs
Predict treatment efficacy
Profile immune response
Identify biomarkers
Single out neutralizing antibodies
Track CAR-T progression
Therapeutic Areas
Immuno-oncology
Infectious Disease Therapeutics
Autoimmune
BROCHURE
Our services offer:
- Comprehensive TCR and BCR repertoire analysis
- Flexible analysis: DNA or RNA sequencing options
- High-touch, expert support from trial planning to data analysis
